Virtual Medicinal Product (VMP)
-
Doxazosin 4mg modified-release tablets
Name Details
Current Name
Doxazosin 4mg modified-release tablets
|
Start Date
SOT
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C02CA04
BNF |
Current BNF
02050400
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02050400
|
Start Date
04-02-2005
|
End Date
03-04-2022
|
Previous BNF
07040100
|
Start Date
04-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39020411000001106 |
23-09-2020 |
|
134456001 |
SOT |
22-09-2020 |
VMP Ingredients
Name
Doxazosin mesilate
Basis of strength description
Based on Base Substance
BOSS
Doxazosin
Strength and UOM (Nmr)
4.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Doxazosin
-
VMP
(Current) Doxazosin 4mg modified-release tablets
Virtual Medicinal Product Pack (VMPP) Information